| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 07/22/2009 | CN100516061C Pyridine derivatives as NMDA receptor ligands |
| 07/22/2009 | CN100515419C Substituted benzazoles and its application as inhibitors of Raf kinase |
| 07/21/2009 | US7563908 2-(1H-indolylsulfanyl)-benzyl amine derivatives as SSRI |
| 07/21/2009 | US7563906 Indazole derivatives |
| 07/21/2009 | US7563905 Triazole derivatives and method of using the same to treat HIV infections |
| 07/21/2009 | US7563895 Quinoxaline compounds |
| 07/21/2009 | US7563812 Amorphous esomeprazole hydrate |
| 07/21/2009 | US7563811 3-(2-Cyanophenyl)-5-(2-methoxyphenyl)-1-phenyl-1,2-dihydropyridin-2-one; antagonists of AMPA and kainate receptors; neuroprotectants; neurodegenerative diseases; Alzheinmer's disease; antiepileptic agents; antispasmodic agents; anxiolytic agents; ddrug abuse; nervous sytem disorders; antihypoxic agents |
| 07/21/2009 | US7563809 Nociceptin analogs |
| 07/21/2009 | US7563807 Removal of aldehyde impurity by reactive polystyrene resini |
| 07/21/2009 | US7563790 Pyridazine derivatives |
| 07/21/2009 | US7563784 substituted 1,1,4-1l6-trioxo[1,2]thiazepan-4-ylamide-derived protease inhibitors which inhibit the likes of cathepsin K; treating osteoporosis, osteo- and rheumatoid arthritis and periodontal disease; inhibiting excessive cartilage or matrix degradation |
| 07/21/2009 | CA2495943C Indoles having anti-diabetic activity |
| 07/16/2009 | WO2009089462A1 5h-cyclopenta[d]pyrimidines as akt protein kinase inhibitors |
| 07/16/2009 | WO2009089132A1 Substituted-aryl-2-phenylethyl-1h-imidazole compounds as subtype selective modulators of alpha 2b and/or alpha 2c adrenergic receptors |
| 07/16/2009 | WO2009089057A1 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same |
| 07/16/2009 | WO2009089042A1 Pyrazole pyrazine amine compounds as kinase inhibitors, compositions thereof and methods of treatment therewith |
| 07/16/2009 | WO2009088997A1 Lactam inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 07/16/2009 | WO2009088857A1 Crystalline solvated forms of (r) -2- [ [ [3-methyl-4- (2, 2, 2-trifluoroethoxy) -2-pyridinyl] methyl] sulfinyl] -1h-benz imidazole |
| 07/16/2009 | WO2009088070A1 (heterocyclic methyl)azolylmethylcyclopentanol derivative and intermediate thereof, process for production of the derivative, and agricultural or horticultural preparation and protective agent for industrial material each comprising the derivative |
| 07/16/2009 | WO2009087684A2 Novel tetrahydroquinolines as aromatase inhibitors |
| 07/16/2009 | WO2009087672A1 A process for preparation of stable amorphous r-lansoprazole |
| 07/16/2009 | WO2009087649A1 Renin inhibitors |
| 07/16/2009 | WO2009087381A1 Pharmaceutically acceptable salts of 2-{4-[(3s)-piperidin-3- yl]phenyl} -2h-indazole-7-carboxamide |
| 07/16/2009 | WO2009087238A2 Chemical molecules that inhibit the slicing mechanism for treating diseases resulting from splicing anomalies |
| 07/16/2009 | WO2009087224A1 Pyrimidines as kinase inhibitors |
| 07/16/2009 | WO2009087212A2 Pyridine derivatives |
| 07/16/2009 | WO2009087127A1 Modulators for amyloid beta |
| 07/16/2009 | WO2009086731A1 New benzimidazole compounds |
| 07/16/2009 | WO2009067166A3 Non-nucleoside reverse transcriptase inhibitors |
| 07/16/2009 | WO2009003999A3 Chemical compounds |
| 07/16/2009 | WO2008138938A3 Process for the production of palladium supported catalysts for catalyzing heck, suzuki-miyaura sonogashira coupling and buchwald-hartwig reactions |
| 07/16/2009 | US20090182144 Binding inhibitor of sphingosine-1-phosphate |
| 07/16/2009 | US20090182143 Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them |
| 07/16/2009 | US20090182007 Organic compounds |
| 07/16/2009 | US20090181996 Substituted quinolones iii |
| 07/16/2009 | US20090181994 Triazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1 |
| 07/16/2009 | US20090181993 Hiv inhibiting 5-heterocyclyl pyrimidines |
| 07/16/2009 | US20090181986 Substituted heterocyclic compounds |
| 07/16/2009 | US20090181979 Pharmaceutically acceptable salts of quinolinone compounds having improved pharmaceutical properties |
| 07/16/2009 | US20090181977 Anhydrous Amorphous Imatinib Mesylate |
| 07/16/2009 | US20090181968 Novel 3-Bicyclocarbonylaminopyridine-2-Carboxamides or 3-Bicyclocarbonylaminopyrazine-2-Carboxamides |
| 07/16/2009 | US20090181967 New compounds I |
| 07/16/2009 | US20090181966 PGD2 receptor antagonists for the treatment of inflammatory diseases |
| 07/16/2009 | US20090181965 Modulators for amyloid beta |
| 07/16/2009 | US20090181964 Propane-1,3-Dione Derivative or Salt Thereof |
| 07/16/2009 | US20090181958 Substituted nitrogen-containing heterobicycles, the preparation thereof and their use as pharmaceutical compositions |
| 07/16/2009 | US20090181956 Hydrazide Compound and Pesticidal Use of the Same |
| 07/16/2009 | US20090181950 Histamine Receptor Antagonists Comprising an Azepin Core |
| 07/16/2009 | US20090181949 1h-imidazole derivative having cb1, agonistic, cb1 partial agonistic or cb1 antagnistic activity |
| 07/16/2009 | US20090181948 Diamine derivative |
| 07/16/2009 | US20090181939 Azetidinecarboxamide Derivatives And Their Use In The Treatment Of CB1 Receptor Mediated Disorders |
| 07/16/2009 | US20090181929 Organic compounds |
| 07/16/2009 | US20090179196 Pyrene-Based Organic Compound, Transistor Material and Light-Emitting Transistor Device |
| 07/16/2009 | CA2738458A1 Crystalline solvated forms of (r)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-1h-benzimidazole |
| 07/16/2009 | CA2711803A1 Pyridine derivatives |
| 07/16/2009 | CA2711782A1 5h-cyclopenta[d]pyrimidines as akt protein kinase inhibitors |
| 07/16/2009 | CA2711652A1 Chemical molecules that inhibit the slicing mechanism for treating diseases resulting from splicing anomalies |
| 07/16/2009 | CA2711637A1 Pyrimidines as kinase inhibitors |
| 07/16/2009 | CA2711491A1 Pharmaceutically acceptable salts of 2-{4-[(3s)-piperidin-3-yl]phenyl}-2h-indazole-7-carboxamide |
| 07/16/2009 | CA2711464A1 Substituted-aryl-2-phenylethyl-1h-imidazole compounds as subtype selective modulators of alpha 2b and/or alpha 2c adrenergic receptors |
| 07/16/2009 | CA2711288A1 Lactam inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 07/16/2009 | CA2707441A1 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same |
| 07/16/2009 | CA2703824A1 Modulators for amyloid beta |
| 07/16/2009 | CA2676477A1 Crystalline solvated forms of (r)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-1h-benzimidazole |
| 07/15/2009 | EP2078716A1 New derivatives of 1H-indol-1-yl-urea, method for preparing same and pharmaceutical compositions containing them |
| 07/15/2009 | EP2078711A1 (Aza)indole derivative substituted in position 5, pharmaceutical composition comprising it, intermediate compounds and preparation process therefor |
| 07/15/2009 | EP2078010A2 Polycyclic heteroaryl substituted triazoles useful as axl inhibitors |
| 07/15/2009 | EP2078009A1 New fluorene derivatives, compositions containing the same and use thereof as inhibitors of the protein chaperone hsp 90 |
| 07/15/2009 | EP2078008A2 Quinoline derivatives for modulating dna methylation |
| 07/15/2009 | EP2078000A1 Benzoyl amino heterocyclyl compounds as glucokinase (glk) activators |
| 07/15/2009 | EP2077997A1 Pyridazine derivatives |
| 07/15/2009 | EP2077841A1 Novel substituted pyrimidines as cysteine protease inhibitors |
| 07/15/2009 | EP1773868B1 Substituted prolines as inhibitors of hepatitis c virus ns3 serine protease |
| 07/15/2009 | EP1426365B1 3-phenoxy-4-pyridazinol derivative and herbicide composition containing the same |
| 07/15/2009 | EP1379514B1 5-membered heterocycles, preparation and application thereof as medicaments |
| 07/15/2009 | CN101484442A Compounds that are agonists of muscarinic receptors and tha may be effective in treating pain, alzheimer's disease and/or schizophrenia |
| 07/15/2009 | CN101484441A Modulators of metabolism and the treatment of disorders related thereto |
| 07/15/2009 | CN101484440A Modulators of metabolism and the treatment of disorders related thereto |
| 07/15/2009 | CN101484439A 4- (2,6-dichloro-benzoylamino) -1h-pyrazole-3-carboxylic acid (1-methanesulphonyl-piperidin-4-yl) -amide for the treatment of cancer |
| 07/15/2009 | CN101484438A Pyrazole derivatives and their use as PI3k inhibitors |
| 07/15/2009 | CN100513405C Chiral ionic compound containing pyrrolidinyl radical and its preparation and application |
| 07/15/2009 | CN100513398C 2-(2-hydroxybiphenyl-3-yl)-1h-benzoimidazole-5-carboxamidine derivatives as factor VIIA inhibitors |
| 07/15/2009 | CN100513397C Pyridine n-oxide compounds as phosphodiesterase 4 inhibitors |
| 07/14/2009 | US7560582 Use of specific bidentate ligands, e.g., 2-dicyclohexylphosphino-2'-dimethylamino-biphenyl, in transition metal-catalyzed carbon-heteroatom and carbon-carbon bond-forming reactions including amination and arylation and with aryl halide reactants and amine, boronic acid, borane or ketone reactants |
| 07/14/2009 | US7560569 (2S,4S)-1-[[(4-carbamoylbicyclo[2.2.2]oct-1-yl)amino]acetyl]-4-fluoropyrrolidine-2-carbonitrile, for treating type II diabetes; increase glucagon-like peptide activity |
| 07/14/2009 | US7560565 Method for preparing derivatives of 3-hydroxypicolinic acid |
| 07/14/2009 | US7560564 Heterocyclic diamide invertebrate pest control agents |
| 07/14/2009 | US7560563 Process for producing 2-substituted pyridine derivative |
| 07/14/2009 | US7560558 quinoline pyridyl derivatives antagonist; antitumor agents; renal disease, hepatic fibrosis, cirrhosis, fibroid lung, scleroderma, wound healing, arthritis, congestive cardiac disease, ulcer, ocular disorder, cornea disorder, diabetic nephropathy |
| 07/14/2009 | US7560553 Use of fuse nicotinamides to promote neurogenesis |
| 07/14/2009 | US7560551 Aurora kinase modulators and method of use |
| 07/14/2009 | US7560547 chemical synthesis of N-[2,4-dibromo-6-methylpyridin-3-yl]-2-[4-(2-hydroxyethyl)piperazin-1-yl]acetamide; used as drugs and chemical intermediates |
| 07/14/2009 | US7560546 Tyrosine kinase inhibitors |
| 07/14/2009 | US7560483 Synthesizing 1- (acyloxy)-alkyl derivatives from 1-acyl-alkyl derivatives, which typically proceeds stereospecifically, in high yield, does not require the use of activated intermediates and/or toxic compounds and is readily amenable |
| 07/14/2009 | US7560481 Indoles are cannabinoid receptor ligands |
| 07/14/2009 | US7560480 Alkyl-containing 5-acylindolinones, the preparation thereof and their use as medicaments |
| 07/14/2009 | US7560472 1-cyclohexylethyl ammonium salts; for inhibiting gastric juice secretion |
| 07/14/2009 | US7560471 5-{4-[1-(2-Ethoxyethyl)-1H-indol-3-yl]piperidin-1-ylmethyl}-2-methoxybenzoic acid; histamine H1 antagonists; bronchial dialtors; asthma; allergic rhinitis; conjunctivitis; dermatitis; urticaria; selective antiallergic effects so less side effect reduction and lower dosage |
| 07/14/2009 | US7560470 Heterocyclyl-3-sulfonylindazoles as 5-hydroxytryptamine-6 ligands |